Literature DB >> 21524475

Erosion of an Amplatzer septal occluder device into the aortic root.

Abdallah Kamouh1, Mohammed Najeeb Osman, Noah Rosenthal, Arie Blitz.   

Abstract

Atrial septal defects can be closed surgically or percutaneously. We report a patient who underwent percutaneous closure of an atrial septal defect with an Amplatzer septal occluder device (AGA Medical Corp, Golden Valley, MN). The patient presented 4 months later with congestive heart failure secondary to an erosion of the Amplatzer septal occluder into the aortic root. The device was removed surgically, and the fistula was repaired. Amplatzer septal occluder indications, selection criteria, and complications are discussed.
Copyright © 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21524475     DOI: 10.1016/j.athoracsur.2010.10.076

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

Review 1.  Atrial septum defect closure device in a beating heart, from the perspective of a researcher in artificial organs.

Authors:  Yasuko Tomizawa
Journal:  J Artif Organs       Date:  2012-06-23       Impact factor: 1.731

Review 2.  AMPLATZER Septal Occluder failure resulting in paradoxical cerebral embolism.

Authors:  Rajeev R Fernando; Ketan P Koranne; Colin M Barker
Journal:  Tex Heart Inst J       Date:  2012

3.  Cost-effectiveness of procedures for treatment of ostium secundum atrial septal defects occlusion comparing conventional surgery and septal percutaneous implant.

Authors:  Márcia Gisele Santos da Costa; Marisa da Silva Santos; Flávia Mori Sarti; Kátia Marie Simões e Senna; Bernardo Rangel Tura; Marcelo Goulart Correia; Marcelo Correia Goulart
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

4.  Cost comparison of transcatheter and operative closures for patients with secundum atrial septal defects in Vietnam.

Authors:  Ho Xuan Tuan; Phan The Phuoc Long; Vu Duy Kien; Harald Kramer; Robert Dalla-Pozza
Journal:  Heliyon       Date:  2021-01-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.